Retatrutide: More Than The Dosage What You need to Know | Mei Mattinson
Published July 20, 2026
Views 11.3K | Likes 175 | Comments 24
At a glance
Views
11,341
Likes
175
Comments
24
Performance vs. channel
Outlier score
Engagement rate
More features coming
We're working on new analytics and tools. Stay tuned.
About
Retatrutide is an investigational triple hormone receptor agonist currently in Phase 3 clinical trials. In this video, you’ll learn how it works, dosing strategies, pharmacokinetics, research findings, clinical outcomes, side effects, and what sets it apart from other GLP-based therapies. Educational purposes only. Th…
- Published
- July 20, 2026
- Made for kids
- No
More features coming
We're working on new analytics and tools. Stay tuned.